SCHEMBL7229294

SCHEMBL7229294

O=C(NCC1Oc2ccccc2O1)c1cccc(CSc2ncnc3[nH]ncc23)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.43
MAPT P10636 3/20 0.43
MAPK1 P28482 1/20 0.43
RAB9A P51151 1/20 0.39
ADORA1 P30542 2/20 0.38
CDC7 O00311 2/20 0.38
DBF4 Q9UBU7 2/20 0.38
CSNK2A2 P19784 1/20 0.36
CSNK2B P67870 1/20 0.36
CSNK2A1 P68400 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
PAK1 Q13153 1/20 0.35
LMNA P02545 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
ROCK2 O75116 1/20 0.35
PARP1 P09874 1/20 0.35
CCNB2 O95067 1/20 0.35
CCNE2 O96020 1/20 0.35
CDK1 P06493 1/20 0.35
CCNB1 P14635 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6846603 0.83 SLC29A1 (0.47) ALDH1A1MAPTMAPK1RAB9AADORA1
SCHEMBL6846871 0.81 LMNA (0.45) ALDH1A1MAPTMAPK1RAB9ASMN1; SMN2
SCHEMBL6844806 0.78 GAA (0.50) ALDH1A1MAPTMAPK1ROCK2POLB
SCHEMBL6846844 0.77 MAPT (0.47) ALDH1A1MAPTMAPK1RAB9ACSNK2A2
SCHEMBL6846427 0.77 NPC1 (0.50) ALDH1A1MAPTMAPK1RAB9ASMN1; SMN2
SCHEMBL6846446 0.77 PAK1 (0.35) ALDH1A1MAPTMAPK1RAB9ASMN1; SMN2
SCHEMBL6841315 0.76 ALDH1A1 (0.48) ALDH1A1MAPTMAPK1RAB9ASMN1; SMN2
SCHEMBL7592061 0.76 ALDH1A1 (0.48) ALDH1A1MAPTMAPK1RAB9ACSNK2A1
SCHEMBL6845380 0.76 ALDH1A1 (0.49) ALDH1A1MAPTMAPK1RAB9ACDC7
SCHEMBL6846677 0.75 ALDH1A1 (0.48) ALDH1A1MAPTMAPK1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6635641-B2 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis AGOURON PHARMACEUTICALS, INC. 2003-10-21 US disclosed
EP-1252146-A1 AMIDE COMPOUNDS FOR INHIBITING PROTEIN KINASES AGOURON PHARMACEUTICALS, INC. (US) 2002-10-30 EP disclosed
WO-2001053274-A1 AMIDE COMPOUNDS FOR INHIBITING PROTEIN KINASES AGOURON PHARMACEUTICALS, INC. (US) 2001-07-26 WO disclosed